Next Phase Newsletter

By Candice He, Vice President of Business Development, Global Investment Strategist, LSN

Are you representing a service provider, big pharma/medtech, or investor looking to connect with innovative life science startups? Don’t miss the upcoming RESI Boston Conference from June 5-7! With over 300 startups from the therapeutics, medical devices, diagnostics, and digital health/healthcare IT sectors expected to attend, this event provides the perfect opportunity to find your next strategic partner or investment opportunity.

As a registered attendee, you’ll have access to a range of networking opportunities, including 1-1 Partnering Meetings. This efficient system allows you to schedule meetings with startups based on a fit of sector, indication and phase of development.

You can also participate in the Innovator’s Pitch Challenge, where you can hear from some of the most promising startups in the industry as they pitch their ideas to seek licensing opportunities and early-stage funding. This is a great way to get a quick overview of what’s new and exciting in the space.

In addition to these opportunities, RESI Boston also offers sponsored workshops and exhibition spaces, where you can showcase your existing programs, products and services, gaining extra exposure from peers and experts.

Check out RESI Sponsorship Brochure

Don’t miss out on this incredible opportunity to connect with cutting-edge startups and gain valuable industry insights. Register for RESI Boston today and take the first step towards building the future of the life sciences industry.

Check out the RESI Boston June 2023 Featured Startups* below:

*As of April 18, 2023

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

Life Science Nation (LSN)’s Redefining Early Stage Investment (RESI) conference stands out from the average partnering conference. LSN, from the start, wanted RESI to be a dedicated partnering-centric event.  RESI content is centered on startups and the information they need to succeed in their fundraising endeavors, comprising of investor and licensing partner panels and service provider workshops (see program guides below). There are two main parts to the equation, the 10,000+ early-stage capital investors and licensing partners in the LSN ecosystem, and the 10,000+ startups that are a fit for RESI. This includes those seeking up to 2M in seed funding, $2-10M series A funding, and $10M to 50M series B funding.

The LSN BD staff are not just selling RESI tickets or the LSN investor database but spend a lot of time assessing and making sure that RESI attendees are ready for a global fundraise and understand what it takes to go from the regional stage to the global arena. LSN really cares about the ROI for our clients. It is because of this challenge I have put a bunch of useful links and info that we send along to our RESI and Data leads so that they know what to expect when designing and launching a global roadshow.

At first glance, there are a lot of links/info, but we have found that startups who really want to understand what LSN and RESI are all about typically take the time to explore the subtlety and nuances of going from a regional to a global roadshow mindset.

• Watch the Introduction to Life Science Nation (LSN)

• Big4Bio Interview

Listen to the podcast from LSN’s CEO, Dennis Ford, about the journey and challenges life sciences entrepreneurs make when they set out to raise money, what investors care about, and what steps they can take to ensure their success best.

• New LSN Executive Summary
• It All Starts With The Story Watch the Recording (28-min)

The most successful entrepreneurs are always the best storytellers. Finding a way to formulate your company’s unique story naturally and portraying this through multiple modalities, whether it be a 1-minute elevator pitch or a 12-slide pitch deck, is one of the most effective ways to get potential investors and partners on board with your value proposition. This video will cover the importance of entrepreneurial agency, finding your voice and developing a compelling narrative for the players that will emerge along a deal chain, and language tools to refine your hook.

• Best Practices for Launching Your Startup Watch the Recording (28-min)

Launching a startup begins with commitment. Commitment to your startup initiative, your executive team, and your partners. Learn how to sustain this commitment by creating a proof of concept or prototype and create market traction initially, considerations to your corporate structure, simplifying finances in the beginning, and what tools to utilize. This video takes you through an honest look at best practices for launching a life science startup.

• RESI Program Guide

• • RESI Boston September 2022
  • RESI JPM January 2023
  • All Program Guides Webpage from past RESIs.

• The Fundraising Manifesto Download e-book, written by LSN’s CEO, Dennis Ford.
• Entrepreneurial Education Courses Download Brochure

Life Science Nation (LSN) has developed a curriculum on the fundamentals of launching a global partnering campaign. 3 different options are available for early-stage life science startups looking to improve their skill set in fundraising, business development, sales, and marketing.

• Download Tear sheet template (Word doc)

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

Redefining Early Stage Investments (the RESI conference series) is a unique gathering. Several hundred startup companies representing cutting-edge technologies from across the verticals of the life sciences attend RESI to meet the huge turnout of investors and to learn about the services that will help them develop and grow their companies.

Visibility and brand recognition with companies that will be raising funds and initiating R&D, pre-clinical, and clinical activities soon is key to add to the leads funnel. RESI gives service providers the chance to have an exhibit table right in the middle of all the activity, as well as a presence online, in our newsletter, and in the program guide.

In addition to meeting the startups, there is the opportunity to meet some of the hundreds of investors and licensing partners that have extensive portfolios of companies in need of crucial services.

For more information, reach out to the LSN Business Development Team!

Life Science Nation Business Development Team
International	East Coast (USA) & China	Midwest (USA) & Canada	West Coast  (USA)
Greg Mannix Vice President International Business Development Book a Meeting Email Me	Candice He VP, Business Development & Global Investment Strategist Book a Meeting Email Me	Antoinette Lowre Manager of Business Development Book a Meeting Email Me	Cameron Hurlburt Manager of Business Development Book a Meeting Email Me

By Joey Wong, Investor Research Analyst, Hong Kong BD, LSN

LSN is once again featuring The Innovator’s Pitch Challenge (IPC) at the upcoming in-person RESI Boston on June 5. The IPC has been immensely popular among life science entrepreneurs and startup founders that attend RESI. The selected finalists will be grouped into sector-themed pitch sessions, and each company will have 4 minutes to present and 8 minutes for Q&A with an investor panel. The IPC offers a unique opportunity for founders and CEOs to engage directly with a panel of seasoned investors, who are specialized in the sectors that they judge for, so that the feedback and questions can be highly practical and constructive for the participants. The IPC is not only popular among startups, it is also valued by many active investors as an efficient way to engage with startups within their sector of interest. Whether you are a startup CEO or an investor, we welcome you to participate in IPC at our upcoming conference.

With two months left until RESI Boston, LSN is organizing an online workshop to help participants prepare for the IPC, ensuring that they can leverage the opportunity to the fullest extent. Please see below for the workshop schedule, and don’t forget to submit your application for the IPC before April 21, the final deadline. We highly recommend you to apply as early as possible, so you will have more time to prepare and maximize your experience. I look forward to seeing you at our webinar next week.

By Karen Deyo, Director of Investor Research, Israel BD, LSN

RESI continues to be successful with a global gathering of early-stage startups, as well as the investors and strategic partners looking to invest in them. Participants from more than 30 countries on 5 continents attended RESI in the past year. Whether it is an in-person or a virtual, each RESI has 1,000+ partnering meetings booked. Individual companies have booked up to 40 meetings over the course of the conference, with more than 75% of meetings booked occurring between companies and investors.

In addition to an extremely active partnering platform, the panels, workshops, and pitch sessions are well-attended and dynamic, with enthusiastic audience participation. We’ll continue to serve life science startups all this great content and provide a wonderful partnering experience in the upcoming RESI Boston June 5-7, with one day in person (June 5) at The Westin Copley Place in Boston, followed by two days (June 6-7) of virtual partnering only. Make sure to register by Friday, April 7th for Super Early Bird tickets to save $500!

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

Every successful entrepreneur will tell you that you have to kiss a lot of frogs before you find discover your prince. Or put more directly, you need to talk to a lot of potential investors and/or licensing partners in order to close a funding round. It really is a numbers game. But how do you identify the hundreds of investment firms out there that would be a fit for your product and stage of development?

LSN has been helping early-stage life science companies develop their Global Target List (GTL) of investors for over 10 years now, based on a couple of very basic premises:

1. Your GTL must be exclusively based on fit.
2. If you have your story straight and have the right tools to present it, you can reach out to your GTL without a warm referral.

A great source for your GTL that LSN has been curating for over 10 years is the LSN Investor Database, tracking 3,000+ investment firms and over 10,000 contacts. Once you filter for your technology and stage of development, you will generate a list of hundreds of investors and licensing partners who are a fit.

COMING SOON:

LSN is continuously looking for ways to improve our offerings to startups by way of new tools and services. Very soon we will be announcing the launch of the GLOBAL PARTNERING CAMPAIGN app, a custom app in a CRM (Customer Relationship Management) program that will combine the benefits of using a CRM to organize your outreach with the powerful LSN Investor Database. Some functions of the platform that will help you stay organized:

• Create your Global Target List from the LSN Database
• Track all of your activities (emails, calls, meeting) with each investor automatically
• Run reports and generate lists for specific activities
• Set task reminders for each investor

If you would like to learn more and see what your own GTL would look like in the LSN Investor Database, just book a meeting with our BD Team below.

Life Science Nation Business Development Team
International	East Coast (USA) & China	Midwest (USA) & Canada	West Coast  (USA)
Greg Mannix Vice President International Business Development Book a Meeting Email Me	Candice He VP, Business Development & Global Investment Strategist Book a Meeting Email Me	Antoinette Lowre Manager of Business Development Book a Meeting Email Me	Cameron Hurlburt Manager of Business Development Book a Meeting Email Me

By Momo Yamamoto, Investor Research Analyst, LSN

RESI Boston June will be back again at The Westin Copley Place on June 5^th in-person followed by virtual partnering on June 6^th – 7^th. The RESI Conference will continue to highlight the Innovator’s Pitch Challenge, educational workshops, and 7 investor panels with investors and strategic partners providing the latest insights to conference attendees.

RESI Boston June will feature a variety of topics for our investor panels, including popular panels such as Big Pharma, Corporate Venture Capital, and MedTech Strategics. Life Science Nation is also excited to introduce new investor panels: Women’s Health and CNS Diseases. All of the panels, new and old, will highlight current industry trends and provide valuable advice from investors and strategic partners to help entrepreneurs with their fundraising efforts. Make sure to register by Friday, April 7^th for Super Early Bird tickets to save $500!